Global Narcolepsy Therapeutics Market Research Report 2022

SKU ID : QYR-21348706 | Publishing Date : 18-Jul-2022 | No. of pages : 82

Request a free Sample

Detailed TOC of Global Narcolepsy Therapeutics Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Central nervous system stimulants
        1.2.3 Sodium Oxybate
        1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
        1.2.5 Tricyclic Antidepressants
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Narcolepsy Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Narcolepsy With Cataplexy
        1.3.3 Narcolepsy Without Cataplexy
        1.3.4 Secondary Narcolepsy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Narcolepsy Therapeutics Market Perspective (2017-2028)
    2.2 Narcolepsy Therapeutics Growth Trends by Region
        2.2.1 Narcolepsy Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Narcolepsy Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Narcolepsy Therapeutics Market Dynamics
        2.3.1 Narcolepsy Therapeutics Industry Trends
        2.3.2 Narcolepsy Therapeutics Market Drivers
        2.3.3 Narcolepsy Therapeutics Market Challenges
        2.3.4 Narcolepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Narcolepsy Therapeutics Players by Revenue
        3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
    3.4 Global Narcolepsy Therapeutics Market Concentration Ratio
        3.4.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2021
    3.5 Narcolepsy Therapeutics Key Players Head office and Area Served
    3.6 Key Players Narcolepsy Therapeutics Product Solution and Service
    3.7 Date of Enter into Narcolepsy Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Therapeutics Breakdown Data by Type
    4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2023-2028)
5 Narcolepsy Therapeutics Breakdown Data by Application
    5.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Narcolepsy Therapeutics Market Size (2017-2028)
    6.2 North America Narcolepsy Therapeutics Market Size by Country (2017-2022)
    6.3 North America Narcolepsy Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Narcolepsy Therapeutics Market Size (2017-2028)
    7.2 Europe Narcolepsy Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Narcolepsy Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Narcolepsy Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Narcolepsy Therapeutics Market Size (2017-2028)
    9.2 Latin America Narcolepsy Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Narcolepsy Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Narcolepsy Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Addrenex Pharmaceuticals, Inc.
        11.1.1 Addrenex Pharmaceuticals, Inc. Company Detail
        11.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
        11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
        11.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
    11.2 Teva Pharmaceutical Industries Ltd.
        11.2.1 Teva Pharmaceutical Industries Ltd. Company Detail
        11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
        11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
    11.3 Jazz Pharmaceuticals PLC
        11.3.1 Jazz Pharmaceuticals PLC Company Detail
        11.3.2 Jazz Pharmaceuticals PLC Business Overview
        11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
        11.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.3.5 Jazz Pharmaceuticals PLC Recent Development
    11.4 Graymark Healthcare, Inc.
        11.4.1 Graymark Healthcare, Inc. Company Detail
        11.4.2 Graymark Healthcare, Inc. Business Overview
        11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
        11.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.4.5 Graymark Healthcare, Inc. Recent Development
    11.5 Arena Pharmaceuticals, Inc.
        11.5.1 Arena Pharmaceuticals, Inc. Company Detail
        11.5.2 Arena Pharmaceuticals, Inc. Business Overview
        11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
        11.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.5.5 Arena Pharmaceuticals, Inc. Recent Development
    11.6 BIOPROJET
        11.6.1 BIOPROJET Company Detail
        11.6.2 BIOPROJET Business Overview
        11.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
        11.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.6.5 BIOPROJET Recent Development
    11.7 Takeda
        11.7.1 Takeda Company Detail
        11.7.2 Takeda Business Overview
        11.7.3 Takeda Narcolepsy Therapeutics Introduction
        11.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.7.5 Takeda Recent Development
    11.8 Ligand Pharmaceuticals, Inc.
        11.8.1 Ligand Pharmaceuticals, Inc. Company Detail
        11.8.2 Ligand Pharmaceuticals, Inc. Business Overview
        11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
        11.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
        11.8.5 Ligand Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Narcolepsy Therapeutics Market Research Report 2022

List of Tables
    Table 1. Global Narcolepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Central nervous system stimulants
    Table 3. Key Players of Sodium Oxybate
    Table 4. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
    Table 5. Key Players of Tricyclic Antidepressants
    Table 6. Key Players of Others
    Table 7. Global Narcolepsy Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Narcolepsy Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Narcolepsy Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Narcolepsy Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Narcolepsy Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Narcolepsy Therapeutics Market Share by Region (2023-2028)
    Table 13. Narcolepsy Therapeutics Market Trends
    Table 14. Narcolepsy Therapeutics Market Drivers
    Table 15. Narcolepsy Therapeutics Market Challenges
    Table 16. Narcolepsy Therapeutics Market Restraints
    Table 17. Global Narcolepsy Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Narcolepsy Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2021)
    Table 20. Ranking of Global Top Narcolepsy Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Narcolepsy Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Narcolepsy Therapeutics Product Solution and Service
    Table 24. Date of Enter into Narcolepsy Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Narcolepsy Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Narcolepsy Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Narcolepsy Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Narcolepsy Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Narcolepsy Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Narcolepsy Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Narcolepsy Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Narcolepsy Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Narcolepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Narcolepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Narcolepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Narcolepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Narcolepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Narcolepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Addrenex Pharmaceuticals, Inc. Company Detail
    Table 45. Addrenex Pharmaceuticals, Inc. Business Overview
    Table 46. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
    Table 47. Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. Addrenex Pharmaceuticals, Inc. Recent Development
    Table 49. Teva Pharmaceutical Industries Ltd. Company Detail
    Table 50. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 51. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product
    Table 52. Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 54. Jazz Pharmaceuticals PLC Company Detail
    Table 55. Jazz Pharmaceuticals PLC Business Overview
    Table 56. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product
    Table 57. Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Jazz Pharmaceuticals PLC Recent Development
    Table 59. Graymark Healthcare, Inc. Company Detail
    Table 60. Graymark Healthcare, Inc. Business Overview
    Table 61. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product
    Table 62. Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Graymark Healthcare, Inc. Recent Development
    Table 64. Arena Pharmaceuticals, Inc. Company Detail
    Table 65. Arena Pharmaceuticals, Inc. Business Overview
    Table 66. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
    Table 67. Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. Arena Pharmaceuticals, Inc. Recent Development
    Table 69. BIOPROJET Company Detail
    Table 70. BIOPROJET Business Overview
    Table 71. BIOPROJET Narcolepsy Therapeutics Product
    Table 72. BIOPROJET Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. BIOPROJET Recent Development
    Table 74. Takeda Company Detail
    Table 75. Takeda Business Overview
    Table 76. Takeda Narcolepsy Therapeutics Product
    Table 77. Takeda Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. Takeda Recent Development
    Table 79. Ligand Pharmaceuticals, Inc. Company Detail
    Table 80. Ligand Pharmaceuticals, Inc. Business Overview
    Table 81. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
    Table 82. Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Ligand Pharmaceuticals, Inc. Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Narcolepsy Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Central nervous system stimulants Features
    Figure 3. Sodium Oxybate Features
    Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Features
    Figure 5. Tricyclic Antidepressants Features
    Figure 6. Others Features
    Figure 7. Global Narcolepsy Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Narcolepsy With Cataplexy Case Studies
    Figure 9. Narcolepsy Without Cataplexy Case Studies
    Figure 10. Secondary Narcolepsy Case Studies
    Figure 11. Narcolepsy Therapeutics Report Years Considered
    Figure 12. Global Narcolepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Narcolepsy Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Narcolepsy Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Narcolepsy Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2021
    Figure 18. North America Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Narcolepsy Therapeutics Market Share by Country (2017-2028)
    Figure 20. United States Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Narcolepsy Therapeutics Market Share by Country (2017-2028)
    Figure 24. Germany Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Narcolepsy Therapeutics Market Share by Region (2017-2028)
    Figure 32. China Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Narcolepsy Therapeutics Market Share by Country (2017-2028)
    Figure 40. Mexico Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Narcolepsy Therapeutics Market Share by Country (2017-2028)
    Figure 44. Turkey Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Narcolepsy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Addrenex Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 47. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 48. Jazz Pharmaceuticals PLC Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 49. Graymark Healthcare, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 50. Arena Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 51. BIOPROJET Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 52. Takeda Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 53. Ligand Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed

Keyplayers in Global Narcolepsy Therapeutics Market Research Report 2022

Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.